|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NEUROPHARMACOLOGY
2-Adrenoceptor Agonist 5-Bromo-N-[4,5-dihydro-1H-imidazol-2-yl]-6-quinoxalinamine (UK14304)
Department of Pharmacology, Meharry Medical College, Nashville, Tennessee (T.A.A); Department of Physiology and Neuroscience, Medical University of South Carolina, Charleston, South Carolina (S.R.); Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, Texas (S.M., L.C.D.); and Department of Pharmacology and Center for Molecular Neuroscience, Vanderbilt University School of Medicine, Nashville, Tennessee (R.D.B.)
Termination of serotonergic transmission is the function of the plasma
membrane 5-hydroxytryptamine (serotonin, 5-HT) transporter (SERT), which is
also a high-affinity target in vivo for antidepressants, amphetamines, and
cocaine. Studies show that SERT is regulated by protein kinase- and
phosphataselinked pathways. In contrast, receptor-linked modulation of SERT is
only minimally defined. Because noradrenergic stimulation is reported to
influence 5-HT release, we explored possible presynaptic adrenoceptor-mediated
regulation of SERT. In mouse forebrain synaptosomes,
2-adrenoceptor agonists, particularly
5-bromo-N-[4,5-dihydro-1H-imidazol-2-yl]-6-quinoxalinamine
(UK14304), triggered a concentration- and time-dependent decrease in 5-HT
transport. In contrast, 5-HT uptake was unaffected by pharmacological
1-adrenoceptor activation. Kinetically, UK14304
significantly decreased the apparent substrate affinity,
Km without altering transport capacity,
Vmax. At concentrations of UK14304 supporting maximal
inhibition of SERT in synaptosomes, no effect on SERT in transfected cells was
observed, suggesting that UK14304 acts indirectly to reduce SERT activity. The
effect of UK14304 on 5-HT uptake was not shared by other Na+ and
Cl-dependent transporters. UK14304-mediated inhibition of
SERT function was yohimbine-sensitive, as was inhibition triggered by
norepinephrine, and was abolished in the absence of added
Ca2+. Moreover, UK14304 effects were attenuated by
voltage-sensitive Ca2+ channel antagonists, consistent
with a role for Ca2+ in UK14304 effects. In agreement
with altered 5-HT transport activity in vitro, in vivo chronoamperometry
studies revealed that UK14304 significantly prolonged 5-HT clearance. Our
findings suggest that UK14304 modulates SERT function in vitro and in vivo via
signaling pathways, possibly supported by an influx of
Ca2+ through voltage-sensitive
Ca2+ channels.
Address correspondence to: Dr. Twum A. Ansah, Department of Pharmacology, Meharry Medical College, 1005 D.B. Todd Blvd., Nashville, TN 37208. E-mail: tansah{at}mmc.edu
This article has been cited by other articles:
![]() |
C.-B. Zhu, J. A. Steiner, J. L. Munn, L. C. Daws, W. A. Hewlett, and R. D. Blakely Rapid Stimulation of Presynaptic Serotonin Transport by A3 Adenosine Receptors J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 332 - 340. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Chen, M. R. Tilley, H. Wei, F. Zhou, F.-M. Zhou, S. Ching, N. Quan, R. L. Stephens, E. R. Hill, T. Nottoli, et al. Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporter PNAS, June 13, 2006; 103(24): 9333 - 9338. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-B. Zhu, A. M. Carneiro, W. R. Dostmann, W. A. Hewlett, and R. D. Blakely p38 MAPK Activation Elevates Serotonin Transport Activity via a Trafficking-independent, Protein Phosphatase 2A-dependent Process J. Biol. Chem., April 22, 2005; 280(16): 15649 - 15658. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Samuvel, L. D. Jayanthi, N. R. Bhat, and S. Ramamoorthy A Role for p38 Mitogen-Activated Protein Kinase in the Regulation of the Serotonin Transporter: Evidence for Distinct Cellular Mechanisms Involved in Transporter Surface Expression J. Neurosci., January 5, 2005; 25(1): 29 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-B. Zhu, W. A. Hewlett, I. Feoktistov, I. Biaggioni, and R. D. Blakely Adenosine Receptor, Protein Kinase G, and p38 Mitogen-Activated Protein Kinase-Dependent Up-Regulation of Serotonin Transporters Involves Both Transporter Trafficking and Activation Mol. Pharmacol., June 1, 2004; 65(6): 1462 - 1474. [Abstract] [Full Text] [PDF] |
||||